Drug General Information (ID: DDI7UW5EQA)
  Drug Name Enoxacin Drug Info Ibuprofen Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiinfective Agents Analgesics
  Structure

 Mechanism of Enoxacin-Ibuprofen Interaction (Severity Level: Moderate)
     Additive CNS depression effects Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Enoxacin Ibuprofen
      Mechanism CNS stimulant effects CNS stimulant effects
      Key Mechanism Factor 1
Factor Name CNS depression effects
Factor Description CNS depressants are drugs that inhibit or suppress brain activity and can reduce mental and physical processes. Excessive CNS depression can lead to decreased heart rate, slow breathing (less than 10 breaths per minute), extreme confusion or loss of memory, nausea and vomiting, poor judgment, blue lips or fingertips, irritability and aggression, and clammy or cold skin.
      Mechanism Description
  • Additive CNS depression effects by the combination of Enoxacin and Ibuprofen 

Recommended Action
      Management Clinical monitoring for signs of CNS stimulation such as tremors, involuntary muscle movements, hallucinations, or seizures is recommended if fluoroquinolone antibiotics are prescribed in combination with NSAIDs.

References
1 Product Information. Factive (gemifloxacin). GeneSoft Inc, San Francisco, CA.
2 Product Information. Raxar (grepafloxacin). Glaxo Wellcome, Research Triangle Park, NC.
3 Product Information. Cipro (ciprofloxacin). Bayer, West Haven, CT.
4 Product Information. Avelox (moxifloxacin) Bayer, West Haven, CT.
5 Product Information. Floxin (ofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.
6 Product Information. Penetrex (enoxacin). Rhone-Poulenc Rorer, Collegeville, PA.
7 Davey PG "Overview of drug interactions with the quinolones." J Antimicrob Chemother 22(suppl c) (1988): 97-107. [PMID: 3053579]
8 Product Information. Tequin (gatifloxacin) Bristol-Myers Squibb, Princeton, NJ.
9 Ball P, Tillotson G "Tolerability of fluoroquinolone antibiotics: past, present and future." Drug Saf 13 (1996): 343-8. [PMID: 8652079]
10 Segev S. Rehavi M, Rubinstein E "Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor." Antimicrob Agents Chemother 32 (1988): 1624-6. [PMID: 2855295]
11 Domagala JM "Structure-activity and structure-side-effect relationships for the quinolone antibacterials." J Antimicrob Chemother 33 (1994): 685-706. [PMID: 8056688]
12 Hooper DC, Wolfson JS "The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans." Antimicrob Agents Chemother 28 (1985): 716-21. [PMID: 2936302]
13 Ball P "Ciprofloxacin: an overview of adverse experiences." J Antimicrob Chemother 18 (1986): 187-93. [PMID: 3542945]
14 Product Information. Levaquin (levofloxacin). Ortho Pharmaceutical Corporation, Raritan, NJ.